Immunology and microbiology devices; reclassification of the herpes simplex virus serological assay device. Final rule.
Fed Regist
; 76(153): 48715-7, 2011 Aug 09.
Article
en En
| MEDLINE
| ID: mdl-21826824
ABSTRACT
The Food and Drug Administration (FDA) is amending the special controls for the herpes simplex virus (HSV) serological assay device type, which is classified as class II (special controls). These device types are devices that consist of antigens and antisera used in various serological tests to identify antibodies to herpes simplex virus in serum, and the devices that consist of herpes simplex virus antisera conjugated with a fluorescent dye (immunofluorescent assays) used to identify herpes simplex virus directly from clinical specimens or tissue culture isolates derived from clinical specimens.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Inmunoensayo
/
Pruebas Serológicas
/
Simplexvirus
/
Seguridad de Equipos
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Humans
País como asunto:
America do norte
Idioma:
En
Año:
2011
Tipo del documento:
Article